Publication | Closed Access

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

Severe InfectionsHealth SciencesAntibioticsAntimicrobial SusceptibilityCarbapenem-resistant Gram-negative BacteriaMicrobiologyInfection ControlAntibiotic ResistanceMedicineClinical MicrobiologyAntimicrobial ResistanceDrug Resistance